Back to Search
Start Over
Citrulline supplementation attenuates the development of non-alcoholic steatohepatitis in female mice through mechanisms involving intestinal arginase
- Source :
- Redox Biology, Redox Biology, Vol 41, Iss, Pp 101879-(2021)
- Publication Year :
- 2021
- Publisher :
- Elsevier BV, 2021.
-
Abstract
- Non-alcoholic fatty liver disease (NAFLD) is by now the most prevalent liver disease worldwide. The non-proteogenic amino acid l-citrulline (L-Cit) has been shown to protect mice from the development of NAFLD. Here, we aimed to further assess if L-Cit also attenuates the progression of a pre-existing diet-induced NAFLD and to determine molecular mechanisms involved. Female C57BL/6J mice were either fed a liquid fat-, fructose- and cholesterol-rich diet (FFC) or control diet (C) for 8 weeks to induce early stages of NASH followed by 5 more weeks with either FFC-feeding +/- 2.5 g L-Cit/kg bw or C-feeding. In addition, female C57BL/6J mice were either pair-fed a FFC +/- 2.5 g L-Cit/kg bw +/- 0.01 g/kg bw i.p. N(ω)-hydroxy-nor-l-arginine (NOHA) or C diet for 8 weeks. The protective effects of supplementing L-Cit on the progression of a pre-existing NAFLD were associated with an attenuation of 1) the increased translocation of bacterial endotoxin and 2) the loss of tight junction proteins as well as 3) arginase activity in small intestinal tissue, while no marked changes in intestinal microbiota composition were prevalent in small intestine. Treatment of mice with the arginase inhibitor NOHA abolished the protective effects of L-Cit on diet-induced NAFLD. Our results suggest that the protective effects of L-Cit on the development and progression of NAFLD are related to alterations of intestinal arginase activity and intestinal permeability.<br />Graphical abstract Image 1<br />Highlights • l-citrulline diminished progression of non-alcoholic fatty liver disease (NAFLD). • l-citrulline protects from fructose-induced small intestinal barrier dysfunction. • NASH development is associated with a loss of arginase activity in small intestine. • l-citrulline improves intestinal arginase activity in diet-induced NAFLD. • Arginase inhibitor attenuates effects of l-citrulline on NAFLD development.
- Subjects :
- 0301 basic medicine
Medicine (General)
F, fructose
Arginine
Clinical Biochemistry
AST, aspartate aminotransferase
Biochemistry
Mice
AUC, area under the curve
NOHA, N(ω)-hydroxy-nor-l-arginine
Liver disease
chemistry.chemical_compound
PCR, polymerase chain reaction
0302 clinical medicine
Non-alcoholic Fatty Liver Disease
ARG2, arginase 2
3-NT, 3-nitrotyrosine
Citrulline
Biology (General)
NAS, NAFLD activity score
Fatty liver
FFC, fat-, fructose- and cholesterol-rich diet
L-Cit, l-citrulline
Arginase
medicine.anatomical_structure
Liver
iNOS, inducible nitric oxide synthase
Female
Research Paper
NAFLD, non-alcoholic fatty liver disease
medicine.medical_specialty
QH301-705.5
C, control diet
NASH, non-alcoholic steatohepatitis
TNFα, tumor necrosis factor alpha
Intestinal permeability
Diet, High-Fat
SEM, standard error of the mean
NO
03 medical and health sciences
R5-920
Tlr4, toll-like receptor 4
4-HNE, 4-hydroxynonenal
ALT, alanine aminotransferase
Internal medicine
medicine
Animals
Hepatic inflammation
Gpr41, G-protein-coupled receptor 41
NO, nitric oxide
business.industry
Bacterial endotoxin
Organic Chemistry
E%, percentage of energy
medicine.disease
ZO-1, zonula occludens 1
Small intestine
GTT, glucose-tolerance-test
Mice, Inbred C57BL
Toll-Like Receptor 4
030104 developmental biology
Endocrinology
chemistry
Dietary Supplements
Myd88, myeloid differentiation primary response 88
Gpr43, G-protein-coupled receptor 43
Steatohepatitis
business
030217 neurology & neurosurgery
Subjects
Details
- ISSN :
- 22132317
- Volume :
- 41
- Database :
- OpenAIRE
- Journal :
- Redox Biology
- Accession number :
- edsair.doi.dedup.....62c29ebb68a39a4a69ad56089e73e70e
- Full Text :
- https://doi.org/10.1016/j.redox.2021.101879